Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Substitutions in position 222 of haemagglutinin of pandemic influenza A (H1N1) 2009 viruses in Spain

  • Ledesma, Juan
  • Pozo Sanchez, Francisco
  • Pérez-Ruiz, Mercedes
  • Navarro, José María
  • Piñeiro, Luis
  • Montes, Milagros
  • Pérez Castro, Sonia
  • Suárez Fernández, Jonathan
  • García Costa, Juan
  • Fernández, Mirian
  • Galán, Juan Carlos
  • Cuevas, Maria Teresa
  • Casas Flecha, Inmaculada
  • Perez-Breña, Pilar
  • Spanish Influenza Surveillance System (SISS)
  • Jimenez-Jorge, Silvia
Background: A change of aspartic acid (D) to glycine (G) at position 222 in the haemagglutinin (HA) protein of pandemic influenza A (H1N1) 2009 viruses was described in Norway on November 2009 with considerable frequency in fatal and severe cases. This change was detected in other countries and was related only with severe disease. Other substitutions to glutamic acid (E) or asparagine (N) at position 222 were detected among pandemic viruses but it is unclear what implications might have in terms of severity. Objectives: To analyse the appearance of amino acid substitutions at position 222 in the HA protein of circulating viruses in Spain and to determine their relationships with the disease symptoms observed. Study design: Pandemic influenza A (H1N1) 2009 viruses detected in respiratory samples of 273 severe and 533 non-severe cases from different Spanish regions were selected for sequencing of a partial segment of HA1 subunit and studied to monitor substitutions at position 222. Results: D222G substitution was only detected in viruses from 14 severe cases (5.12%). D222E was found in viruses from 47 severe (17.21%) and from 52 non-severe cases (9.75%). D222N occurred in viruses from 3 additional severe cases (0.37%). Conclusion: Appearance of D222G and D222E substitution in HA of pandemic influenza A (H1N1) viruses circulating in Spain might be related with severe respiratory disease.
Repisalud
Publication Artículo científico (JournalArticle)

Genetic diversity of influenza A(H1N1)2009 virus circulating during the season 2010-2011 in Spain

  • Ledesma, Juan
  • Pozo Sanchez, Francisco
  • Reina, Gabriel
  • Blasco, Miriam
  • Rodríguez, Guadalupe
  • Montes, Milagrosa
  • López-Miragaya, Isabel
  • Salvador, Carmen
  • Reina, Jordi
  • Ortíz de Lejarazu, Raúl
  • Egido, Pilar
  • López Barba, José
  • Delgado-Sanz, Concepcion
  • Cuevas, Maria Teresa
  • Casas Flecha, Inmaculada
  • Spanish Influenza Surveillance System (SISS)
  • Larrauri, Amparo
  • Jimenez-Jorge, Silvia
Background: Genetic diversity of influenza A(H1N1)2009 viruses has been reported since the pandemic virus emerged in April 2009. Different genetic clades have been identified and defined based on amino acid substitutions found in the haemagglutinin (HA) protein sequences. In Spain, circulating influenza viruses are monitored each season by the regional laboratories enrolled in the Spanish Influenza Surveillance System (SISS). The analysis of the HA gene sequence helps to detect the genetic diversity and viral evolution. Objectives: To perform an analysis of the genetic diversity of influenza A(H1N1)2009 viruses circulating in Spain during the season 2010-2011 based on analysis of the HA sequence gene. Study design: Phylogenetic analysis based on the HA1 subunit of the haemagglutinin gene was carried out on 220 influenza A(H1N1)2009 viruses circulating during the season 2010-2011. Results: Six different genetic groups were identified among circulating A(H1N1)2009 viruses, five of them were previously reported during season 2010-2011. A new group, characterized by E172K and K308E changes and a proline at position 83, was observed in 12.27% of the Spanish viruses. Conclusion: Co-circulation of six different genetic groups of influenza A(H1N1)2009 viruses was identified in Spain during the season 2010-2011. Nevertheless, at this stage, none of the groups identified to date have resulted in significant antigenic changes according to data collected by World Health Organization Collaborating Centres for influenza surveillance.
Repisalud
Publication Artículo científico (JournalArticle)

Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain

  • Ledesma, Juan
  • Vicente, Diego
  • Pozo Sanchez, Francisco
  • Cilla, Gustavo
  • Pérez Castro, Sonia
  • Suárez Fernández, Jonathan
  • Pérez-Ruiz, Mercedes
  • Navarro, José María
  • Galán, Juan Carlos
  • Fernández, Mirian
  • Reina, Jordi
  • Larrauri, Amparo
  • Cuevas, Maria Teresa
  • Casas Flecha, Inmaculada
  • Perez-Breña, Pilar
  • Spanish Influenza Surveillance System (SISS)
  • Jimenez-Jorge, Silvia
Background: Pandemic influenza A (H1N1) 2009 virus appeared in Spain on April 25, 2009 for the first time. This new virus was adamantane-resistant but it was sensitive to neuraminidase (NA) inhibitors oseltamivir and zanamivir. Objectives: To detect oseltamivir-resistant pandemic influenza A (H1N1) 2009 viruses by the Spanish Influenza Surveillance System (SISS) and a possible spread of oseltamivir-resistant viruses in Spain since starting of the pandemic situation. Study design: A total of 1229 respiratory samples taken from 413 severe and 766 non-severe patients with confirmed viral detection of pandemic influenza A (H1N1) 2009 viruses from different Spanish regions were analyzed for the specific detection of the H275Y mutation in NA between April 2009 and May 2010. Results: H275Y NA substitution was found in 8 patients infected with pandemic influenza A (H1N1) 2009 viruses collected in November and December 2009 and in January 2010. All oseltamivir-resistant viruses were detected in severe patients (8/413, 1.93%) who previously received treatment with oseltamivir. Six of these patients were immunocompromised. Conclusion: In Spain, the number of oseltamivir-resistant pandemic influenza A (H1N1) 2009 viruses is until now very low. No evidence for any spread of oseltamivir-resistant H1N1 viruses is achieved in our Country.